These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10835926)

  • 1. [Peritoneal transport of amino acids in continuous ambulatory peritoneal dialysis (CAPD)].
    Olszowska A; Baczyński D
    Pol Arch Med Wewn; 1999 Jul; 102(1):629-33. PubMed ID: 10835926
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of peritoneal transport of solutes and water in patients treated with peritoneal analysis].
    Baczyński D; Olszowska A; Wańkowicz Z
    Pol Arch Med Wewn; 1999 Jul; 102(1):621-7. PubMed ID: 10835925
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluid and solute transport across the peritoneum during continuous ambulatory peritoneal dialysis (CAPD).
    Krediet RT; Arisz L
    Perit Dial Int; 1989; 9(1):15-25. PubMed ID: 2488175
    [No Abstract]   [Full Text] [Related]  

  • 4. Longitudinal changes of solute transport in peritonitis-free peritoneal dialysis patients.
    Hung SY; Hung YM; Chiou YH; Chou KJ; Chung HM
    Artif Organs; 2004 Mar; 28(3):254-8. PubMed ID: 15046623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alternative dialysis solutions in continuous ambulatory peritoneal dialysis].
    Olszowska A; Baczyński D
    Pol Merkur Lekarski; 1998 Nov; 5(29):307-9. PubMed ID: 10101509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal transport kinetics with amino acid-based and glucose-based peritoneal dialysis solutions.
    Rippe B; Venturoli D
    Perit Dial Int; 2007; 27(5):518-22. PubMed ID: 17704439
    [No Abstract]   [Full Text] [Related]  

  • 7. [The introduction to continuous ambulatory peritoneal dialysis (CAPD)].
    Sanaka T; Ikehara O
    Nihon Rinsho; 2004 May; 62 Suppl 5():269-74. PubMed ID: 15197928
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of peritoneal transport in patients with failed renal allografts receiving CAPD.
    Tobe S; Chu MG; Bargman JM
    Adv Perit Dial; 1991; 7():39-43. PubMed ID: 1680454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular complications versus adequacy and peritoneal transport characteristics in CAPD patients].
    Antosiewicz S; Baczyński D; Wańkowicz Z
    Pol Arch Med Wewn; 1999 Jul; 102(1):595-601. PubMed ID: 10835921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-dependent variations in peritoneal membrane transport properties in CAPD patients.
    Ates K; Ertürk S; Nergisoglu G; Karatan O; Duman N; Erbay B; Ertuğ AE
    Nephrol Dial Transplant; 1996 Nov; 11(11):2375-6. PubMed ID: 8941626
    [No Abstract]   [Full Text] [Related]  

  • 11. [When the peritoneum serves as a natural filter. Potentials and limitations of peritoneal dialysis].
    Pflege Z; 1999 Jan; 52(1):24-5. PubMed ID: 10427259
    [No Abstract]   [Full Text] [Related]  

  • 12. How does peritoneal dialysis remove small and large molecular weight solutes? Transport pathways: fact and myth.
    Rippe B; Stelin G
    Adv Perit Dial; 1990; 6():13-8. PubMed ID: 1982790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of diabetes on peritoneal function assessed by personal dialysis capacity test in patients undergoing CAPD.
    Nakamoto H; Imai H; Kawanishi H; Nakamoto M; Minakuchi J; Kumon S; Watanabe S; Shiohira Y; Ishii T; Kawahara T; Tsuzaki K; Suzuki H
    Am J Kidney Dis; 2002 Nov; 40(5):1045-54. PubMed ID: 12407651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD: a biological membrane and a non-biological fluid.
    Jörres A
    Contrib Nephrol; 2003; (140):1-9. PubMed ID: 12800338
    [No Abstract]   [Full Text] [Related]  

  • 15. Does posture modify solute transport in CAPD?
    Otero A; Esteban J; Canovas L
    Perit Dial Int; 1992; 12(4):399-400. PubMed ID: 1420502
    [No Abstract]   [Full Text] [Related]  

  • 16. Computation of the dose of continuous peritoneal dialysis required for adequate peritoneal urea clearance without taking into account peritoneal transport indices.
    Tzamaloukas AH; Onime A; Raj DS; Murata GH; VanderJagt DJ; Servilla KS
    Adv Perit Dial; 2007; 23():122-6. PubMed ID: 17886617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
    Douma CE; de Waart DR; Struijk DG; Krediet RT
    Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Charge selectivity of peritoneal transport in CAPD patients under stable states and during peritonitis].
    Nakao T; Ogura M; Okada T; Hann M; Takahashi H; Kanebayashi Y; Shino T
    Nihon Jinzo Gakkai Shi; 1996 Nov; 38(11):502-6. PubMed ID: 8958704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the daily dialysate drain volume required in CAPD for a target peritoneal creatinine clearance by body water and peritoneal transport characteristics.
    Rao P; Tzamaloukas AH; Murata GH; Piraino B; Malhotra D; Bernardini J; Oreopoulos DG
    Adv Perit Dial; 1997; 13():33-7. PubMed ID: 9360647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Icodextrin as first treatment: reasons to be optimistic].
    Rivera M
    Nefrologia; 2009; 29(2):99-102. PubMed ID: 19396313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.